Diet and benign prostatic hyperplasia: A study in Greece

Urology

Volumn 54, Issue 2, 1999, Pages 284-290

  Lagiou, P ^a,b   Wuu, J ^c   Trichopoulou, A ^b   Hsieh, C C ^c   Adami, H O ^d,e   Trichopoulos, D ^a,e  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MARGARINE; OLIVE OIL; VEGETABLE OIL; ZINC;

ADULT; AGED; ARTICLE; BUTTER; CASE CONTROL STUDY; CONTROLLED STUDY; DIET; FRUIT; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK FACTOR;

CASE-CONTROL STUDIES; DIET; GREECE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA;

EID: 0032795189     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00096-5     Document Type: Article

References (32)

1. Glynn R.J., Campion E.W., Bouchard G.R., et al. The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol. 121:1985;78-90.
2. Chute C.G., Stephenson W.P., Guess H.A., et al. Benign prostatic hyperplasia a population-based study . Eur Urol. 20:(suppl 2):1991;11-17.
3. Gann P.H., Hennekens C.H., Longcope C., et al. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate. 26:1995;40-49.
4. Blom J.H., Schroder F.H. Epidemiology and natural course of benign prostatic hyperplasia. Urologe A. 31:1992;129-134.
5. Sidney S., Quesenberry C. Jr, Sadler M.C., et al. Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among black and white multiphasic examinees in a prepaid health care plan. Am J Epidemiol. 134:1991;825-829.
6. Moon T.D., Brannan W., Stone N.N., et al. Effect of age, educational status, ethnicity and geographical location on prostate symptom scores. J Urol. 152:1994;1498-1500.
7. Dunzendorfer U., Drahovsky D. C-peptide, testosterone, estrogen, cortisol and zinc in patients with benign prostatic hyperplasia of the prostate. Urol Int. 35:1980;369-374.
8. Dutkiewicz S. Zinc and magnesium serum levels in patients with benign prostatic hyperplasia (BPH) before and after prazosin therapy. Mater Med Pol. 27:1995;15-17.
9. Zaichick V.Y., Sviridova T.V., Zaichick S.V. Zinc in the human prostate gland normal, hyperplastic and cancerous . Int Urol Nephrol. 29:1997;565-574.
10. Liu Y., Franklin R.B., Costello L.C. Prolactin and testosterone regulation of mitochondrial zinc in prostate epithelial cells. Prostate. 30:1997;26-32.
11. Willden E.G., Robinson M.R. Plasma zinc levels in prostatic disease. Br J Urol. 47:1975;295-299.
12. Tisell L.E., Fjelkegard B., Liessner K.H. Zinc concentration and content of the dorsal, lateral and medial prostatic lobes and of periurethral adenomas in man. J Urol. 128:1982;403-405.
13. Leake A., Chrisholm G.D., Busuttil A., et al. Subcellular distribution of zinc in the benign and malignant human prostate evidence for a direct zinc androgen interaction . Acta Endocrinol (Copenh). 105:1984;281-288.
14. Feustel A., Wennrich R. Zinc and cadmium in cell fractions of prostatic cancer tissues of different histological grading in comparison to BPH and normal prostate. Urol Res. 12:1984;147-150.
15. Lahtonen R. Zinc and cadmium concentrations in whole tissue and in separated epithelium and stroma from human benign hypertrophic glands. Prostate. 6:1985;177-183.
16. Gnardellis C., Trichopoulou A., Katsouyanni K., et al. Reproducibility and validity of an extensive semi-quantitative food frequency questionnaire among Greek schoolteachers. Epidemiology. 6:1995;74-77.
17. Katsouyanni K., Skalkidis Y., Petridou E., et al. Diet and peripheral arterial occlusive disease the role of poly, mono, and saturated fatty acids . Am J Epidemiol. 133:1991;24-31.
18. Davidson S.S., Passmore R. Human Nutrition and Dietetics. 1979;Churchill Livingstone, Edinburgh.
19. Manousos O., Day N., Trichopoulos D., et al. Diet and colorectal cancer a case-control study in Greece . Int J Cancer. 32:1983;1-5.
20. Manousos O., Day N., Tzonou A., et al. Diet and other factors in the aetiology of diverticulosis an epidemiological study in Greece . Gut. 26:1985;544-549.
21. Trichopoulou A., Katsouyanni K., Stuver S., et al. Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J Natl Cancer Inst. 87:1995;110-116.
22. Trichopoulou A: Composition of Greek Foods and Dishes (in Greek and English). Athens, Greece, Athens School of Public Health, 1992.
23. Katsouyanni K, Trichopoulou A, Trichopoulos D, et al: Dietary Variability in Greece. A Report to the Secretariat of Research and Technology. Athens, Greece, Ministry of Industry, Research and Technology, 1991, pp 1-64.
24. Statistical Analysis Systems: SAS User's Guide, Statistics, version 6.04. Cary, North Carolina, SAS Institute, 1995.
25. MacMahon B., Trichopoulos D. Epidemiology Principles and Methods . 1996;Boston, Little, Brown.
26. Katsouyanni K., Trichopoulou A., Stuver S., et al. The association of fat and other macronutrients with breast cancer a case-control study from Greece . Br J Cancer. 70:1994;537-541.
27. Rothman K.J. Modern Epidemiology. 1986;Boston, Little, Brown.
28. Araki H., Watanabe H., Mishina T., et al. High-risk group for benign prostatic hypertrophy. Prostate. 4:1983;253-264.
29. Chyou P.-H., Nomura A.M.Y., Stemmermann G.N., et al. A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate. 22:1993;253-264.
30. Brys M., Nawrocka A.D., Miekos E., et al. Zinc and cadmium analysis in human prostate neoplasms. Biol Trace Element Res. 59:1997;145-152.
31. Wilson J.D. The pathogenesis of benign prostatic hyperplasia. Am J Med. 68:1980;745-755.
32. Leake A., Chrisholm G.D., Habib F.K. The effect of zinc on the 5 alpha-reduction of testosterone by the hyperplastic human prostate gland. J Steroid Biochem. 20:1984;651-655.